Ph2 Pan-Tumor Study of Ifnatamab Deruxtecan in Pts with Met Solid Tumors
Phase
Phase II Clinical Trial
Condition(s)
Colon Cancer, Endometrial Cancer, Gastric Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Pancreatic Cancer
Trial Number
06330064
Trial Status
OPEN
Study Overview
A Phase 1b/2 Pan-Tumor Open-Label Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (Ideate-PanTumor02) (DS7300-203)
